Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide - Wikidata - awgldk - TriplyDB

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

http://www.wikidata.org/entity/Q28362078

about

Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system CB2 receptor-mediated migration of immune cells: it can go either way The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors The endocannabinoid system as an emerging target of pharmacotherapy Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction Cannabinoids and Epilepsy.Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.Medical cannabis - the Canadian perspective Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect Virtualizing the p-ANAPL library: a step towards drug discovery from African medicinal plants Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation Cannabinoids, eating behaviour, and energy homeostasis.Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation.Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice.Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.Transient receptor potential (TRP) channels: a clinical perspective Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.Endocannabinoids in the dentate gyrus.Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats.The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder.

P2860

Q21132308-684AFD39-E2B1-4064-AB1A-F37E71B7D6A3 Q24606148-769A32F1-6815-4CAA-B76A-747F20169AB9 Q24607361-E2FD727F-F5EB-439B-B449-848B7B5DB3E5 Q24622202-4899ED5C-B394-4284-A33E-56E6985B19CC Q24623179-3E6AE828-7933-4BE8-9B21-BD74B059820E Q24626361-ECA79D2B-BB27-4F4A-B71B-366BAAD3DCB5 Q24627020-C15A4D75-F80F-4ADC-AAA7-9CAB93A072B2 Q24643591-8992D553-D60C-4A0A-8E4A-AF8ADCB0C582 Q24643876-00417905-4F36-4070-B39D-4CF62A420E6B Q24644922-AFB1F21E-F3ED-446E-A4A9-7DA5E03C4D20 Q24645241-E95F5055-0135-44A6-BF23-2D86FC2D944F Q24646841-10A2B5E8-BD42-41D5-8660-760B4ED7B109 Q24648473-51F0CCEF-4D4D-4B94-934C-C2D05AE5EED8 Q26770823-68125218-2A03-4624-8944-B1755CFE1620 Q27014154-036B26C1-274F-43BE-BEF5-CF02F4A759A8 Q27336451-829FD6BF-0EC3-432A-97C9-442CBF5D6749 Q27336497-2ECE05AA-0F1A-42A8-BCCE-B81A5DBB9DF2 Q28069855-2353E686-60F4-40FC-B0B1-7DB434EF2DC2 Q28075499-32A268CB-773C-473A-8E01-341989596FDB Q28285577-3B737CF0-8513-41E3-B312-9EE9906C312B Q28298445-07DC91B1-2DAF-4C6F-9A4F-9AAA4A615DCF Q28534561-BE405EF0-FBBB-45BA-9271-672D8D8C8A59 Q28540495-F2B7B638-0E3F-4D81-ABFA-807F8DC99197 Q28576747-0D2C5585-EC82-4166-A4AA-DF11434144CF Q28583653-51B206A4-0AD9-4C65-A67B-91098698A85A Q30357350-1B8885E5-8CB4-47CE-8661-68E70D922BED Q30367009-1FFE55D7-F396-4A33-A08E-25F70DBA12BD Q30442731-5211F67B-6E4E-4B3E-9797-1345435AC233 Q30446489-E1FC6447-BBF1-45EA-A27F-BDC93B695294 Q30468504-06508682-C3E7-4633-A0D6-C1EC7DBCBF19 Q30473707-2D634279-264E-483A-B836-58AC438EC43D Q30493082-0F292CBD-52AE-4D35-8B9D-50AC3F8EC664 Q33562143-84E9F5B0-0B8E-4CDB-8C3A-BDB8413D083D Q33564023-75216D20-EB5D-4367-BDA1-62B0929C8C5F Q33757950-3D392AAE-427E-46D0-A182-1141849AFD0C Q33819365-C95F8A45-5538-4CE0-ADBC-CB72B43ACF91 Q33819645-E9C7C17B-BD5B-4AB4-8F7A-C8AC094978B9 Q33861917-243B22F1-D394-440B-8402-535D76884071 Q33869556-2BA77D0E-9C0A-4D68-AC34-7742B1819654 Q33897251-D1DBEE35-5CB9-49FF-A964-EBBDC34BAD92

P2860

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

http://www.wikidata.org/entity/Q28362078

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

name

Molecular targets for cannabid ...... matic hydrolysis of anandamide

@ast

Molecular targets for cannabid ...... matic hydrolysis of anandamide

@en

Molecular targets for cannabid ...... matic hydrolysis of anandamide

@nl

type

label

Molecular targets for cannabid ...... matic hydrolysis of anandamide

@ast

Molecular targets for cannabid ...... matic hydrolysis of anandamide

@en

Molecular targets for cannabid ...... matic hydrolysis of anandamide

@nl

prefLabel

Molecular targets for cannabid ...... matic hydrolysis of anandamide

@ast

Molecular targets for cannabid ...... matic hydrolysis of anandamide

@en

Molecular targets for cannabid ...... matic hydrolysis of anandamide

@nl

P1433

Q28362078-3155A57E-D46A-4468-BB94-99A28A5C661D

P1476

Q28362078-75D715CD-EDDB-4FE8-82C5-5901E59AF178

P2093

Q28362078-02796EC7-EF1A-45B5-931C-0DF7861A3B32

Q28362078-10F072A7-94E1-4A32-9BC6-44A9C9D3FE98

Q28362078-25648FDE-58A0-4634-90C6-336F4F8A3142

Q28362078-49C1580B-F9DA-468F-8FB1-B45E6A7982BE

Q28362078-8AE93E74-41BC-4413-9CF6-DAFA62B78EFA

Q28362078-8FBBC12D-11EF-48FA-93F0-F2CCF0C5D07F

Q28362078-A711D38B-0428-472A-A9A8-62C231FD7319

Q28362078-A86B58F3-71C8-4413-B934-F02C7A99BD11

Q28362078-BE8CE553-BFF6-41B3-BE26-717865576186

P2860

Q28362078-03AEF0C1-1514-4842-9052-AD3F1C11581B

Q28362078-0537DC07-4139-49F8-BCAF-097ED0EDCC9A

Q28362078-05608875-7DB3-45BD-ADA0-33226D33C912

Q28362078-0C131EBE-C551-4F4E-8BE0-F6DAE725024F

Q28362078-16A4BBE8-F9D4-4F4B-851B-C1B362C91F2D

Q28362078-17B4A7D6-0284-482C-8A78-C3AA6523EBA6

Q28362078-1C8B2B1A-C4E9-49E2-ACD4-A098B0D7A576

Q28362078-2068398B-F1DF-4ED8-8E03-75095D423808

Q28362078-27E7284D-F006-4274-B93C-82EB1D62B225

Q28362078-284BF40E-A38D-4FCD-9BEC-42134DA58920

P304

Q28362078-44206E14-C360-425F-BB5F-8D6DD331AD06

P31

Q28362078-FB8C1053-C082-407F-A45D-5BE5B0AE9CE1

P3181

Q28362078-D827DAAC-C2B3-4489-A369-DB6E0B1ED58E

P356

Q28362078-D10A60CD-6D2D-44D1-A889-2419DDF565BA

P407

Q28362078-780FCD33-0E0C-4443-AF7C-134A065D0D78

P433

Q28362078-4525C03B-25B3-4010-8AF4-BE3B74DBB853

P478

Q28362078-26CDB7F1-D692-4AB4-975B-CFE1A93C0576

P50

Q28362078-54B85E69-0A18-4001-AA16-2EC7BA273642

P577

Q28362078-547E2899-BD6F-4B8E-98C8-3E00B223F6F2

P5875

Q28362078-2EE593B5-65B4-4CA3-854D-3633F55F88B9

P698

Q28362078-C07804AD-E173-4123-A725-03EFE6C4BEA9

P921

Q28362078-515148B5-9ABA-479A-8108-AD040CFA9CED

Q28362078-806C4A1A-DBF1-4A57-AE30-B22A78DE75C5

Q28362078-9841E4B8-4615-45C8-8795-26D71B599FFF

P932

Q28362078-2AD1DF8F-374F-40B5-8416-0B60CCBB4261

P3181

P356

P1433

British Journal of Pharmacology

P1476

Molecular targets for cannabid ...... matic hydrolysis of anandamide

@en

P2093

A S Moriello

http://www.w3.org/2001/XMLSchema#string

D E Ponde

http://www.w3.org/2001/XMLSchema#string

I Brandi

http://www.w3.org/2001/XMLSchema#string

J B Davis

http://www.w3.org/2001/XMLSchema#string

L De Petrocellis

http://www.w3.org/2001/XMLSchema#string

L Hanus

http://www.w3.org/2001/XMLSchema#string

S Tchilibon

http://www.w3.org/2001/XMLSchema#string

T Bisogno

http://www.w3.org/2001/XMLSchema#string

V Di Marzo

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

A novel probe for the cannabinoid receptor

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1.

Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

Impaired nociception and pain sensation in mice lacking the capsaicin receptor

P304

845-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2624134

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.BJP.0704327

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Raphael Mechoulam

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227740357

http://www.w3.org/2001/XMLSchema#string

P698

11606325

http://www.w3.org/2001/XMLSchema#string

P921

P932

1573017

http://www.w3.org/2001/XMLSchema#string